High EZH2 Expression Accompanied by Low H3K27me3 Predicts Poorer Outcome in Metaplastic Carcinoma of the Breast

被引：0
|
作者：
Tan, Benjamin Yongcheng [1 ]
Ong, Clara [1 ]
Koh, Valerie [1 ]
Thike, Aye Aye [1 ]
Tan, Puay-Hoon [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
291
引用
收藏
页码：74A / 75A
页数：2
相关论文
共 50 条
  • [41] Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3
    Yu, Yongxin
    Deng, Peng
    Yu, Bo
    Szymanski, John M.
    Aghaloo, Tara
    Hong, Christine
    Wang, Cun-Yu
    STEM CELL REPORTS, 2017, 9 (03): : 752 - 761
  • [42] The role of EZH2 and H3K27me3 epigenetic signature in modulating T-cell polarization in atherosclerosis
    Bonfiglio, C. A.
    Lacy, M.
    Janjic, A.
    Kucukgoze, I. Avcilar
    Nitz, K.
    Wu, Y.
    Wange, L. E.
    Santovito, D.
    Bosmans, L. A.
    Imhof, A.
    Enard, W.
    Weber, C.
    De Winther, M.
    Lutgens, E.
    Atzler, D.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [43] H3K27me3 Expression Correlates With Patient Outcome In Cervical Cancer
    da Mata, Sara
    Ferreira, Joana
    Silva, Fernanda
    Felix, Ana
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 673 - 674
  • [44] Evaluation of H3K27me3 Expression as a Marker of EZH2 Activation in SMARCA4/SMARCA2-Deficient Tumors and Candidate Biomarker for Trials of EZH2 Inhibitors
    Kezlarian, Brie
    Montecalvo, Joseph
    Sauter, Jennifer
    Travis, William
    Gounder, Mrinal
    Rudin, Charles
    Ladanyi, Marc
    Namakydoust, Azadeh
    Rekhtman, Natasha
    LABORATORY INVESTIGATION, 2019, 99
  • [45] Evaluation of H3K27me3 Expression as a Marker of EZH2 Activation in SMARCA4/SMARCA2-Deficient Tumors and Candidate Biomarker for Trials of EZH2 Inhibitors
    Kezlarian, Brie
    Montecalvo, Joseph
    Sauter, Jennifer
    Travis, William
    Gounder, Mrinal
    Rudin, Charles
    Ladanyi, Marc
    Namakydoust, Azadeh
    Rekhtman, Natasha
    MODERN PATHOLOGY, 2019, 32
  • [46] H3K27me3 Expression Correlates With Patient Outcome In Cervical Cancer
    da Mata, Sara
    Ferreira, Joana
    Silva, Fernanda
    Felix, Ana
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 673 - 674
  • [47] Loss of H3K27Me3 Expression in Osteosarcoma
    Wang, Wei-Lien Billy
    Livingston, John A.
    Liang, Yu
    Leung, Cheuk Hong
    Lin, Heather
    Lazar, Alexander
    LABORATORY INVESTIGATION, 2018, 98 : 39 - 39
  • [48] Loss of H3K27Me3 Expression in Osteosarcoma
    Wang, Wei-Lien Billy
    Livingston, John A.
    Liang, Yu
    Leung, Cheuk Hong
    Lin, Heather
    Lazar, Alexander
    MODERN PATHOLOGY, 2018, 31 : 39 - 39
  • [49] The EZH2–PRC2–H3K27me3 axis governs the endometrial cell cycle and differentiation for blastocyst invasion
    Yamato Fukui
    Yasushi Hirota
    Shizu Aikawa
    Akihiko Sakashita
    Ryoko Shimizu-Hirota
    Norihiko Takeda
    Chihiro Ishizawa
    Rei Iida
    Tetsuaki Kaku
    Tomoyuki Hirata
    Takehiro Hiraoka
    Shun Akaeda
    Mitsunori Matsuo
    Yutaka Osuga
    Cell Death & Disease, 14
  • [50] MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2
    Yu, Hui
    Xu, Xianrong
    Zhu, Lirong
    Chen, Shengjie
    He, Jincheng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (08)
12345